Literature DB >> 11015342

Homozygosity for 807 T polymorphism in alpha(2) subunit of platelet alpha(2)beta(1) is associated with increased risk of cardiovascular mortality in high-risk women.

M Roest1, J D Banga, D E Grobbee, P G de Groot, J J Sixma, M J Tempelman, Y T van der Schouw.   

Abstract

BACKGROUND: Platelet adhesion to collagen is the initial step in both hemostasis and thrombosis; this adhesion is mediated by alpha(2)beta(1) on the surface of platelet membranes. An 807 C to T single nucleotide exchange polymorphism close to the gene coding for the alpha(2) subunit of alpha(2)beta(1) is associated with the density of alpha(2)beta(1) on the platelet membrane. METHODS AND
RESULTS: We studied the relation of the alpha(2)beta(1) 807 C/T genotype to cardiovascular mortality in a prospective cohort study of 12 239 women who were invited for the breast cancer screening program of Utrecht, the Netherlands. The initial age was between 52 and 67 years. Women were followed on vital status between 1976 and 1995 (168 513 women-years). Data were analyzed by using a nested case-control design. The alpha(2)beta(1) 807 C/T genotype was not associated with cardiovascular mortality in the total population: the rate ratio for cardiovascular mortality in 807 TT homozygotes compared with 807 CC wild types was 1.2 (95% CI 0.8 to 1.7). However, the alpha(2)beta(1) 807 T polymorphism was associated with an increased risk of cardiovascular mortality in women who smoked or in women who had indications of compromised endothelium, such as diabetes and microalbuminuria. In those who were exposed to >/=2 of these factors, the risk ratio (95% CI) between alpha(2)beta(1) 807 TT homozygotes and 807 CC wild types was 14.1 (5.0 to 39.9).
CONCLUSIONS: alpha(2)beta(1) 807 TT homozygosity, coding for increased alpha(2)beta(1) density on the platelet membrane, is associated with an increased risk of cardiovascular mortality in those women with indications of compromised endothelium.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11015342     DOI: 10.1161/01.cir.102.14.1645

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  10 in total

Review 1.  Role of platelet glycoprotein polymorphisms in cardiovascular diseases.

Authors:  Christian Meisel; José A López; Karl Stangl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-11-12       Impact factor: 3.000

2.  hnRNP L regulates differences in expression of mouse integrin alpha2beta1.

Authors:  Yann Cheli; Thomas J Kunicki
Journal:  Blood       Date:  2006-02-02       Impact factor: 22.113

Review 3.  The pharmacogenetic control of antiplatelet response: candidate genes and CYP2C19.

Authors:  Yao Yang; Joshua P Lewis; Jean-Sébastien Hulot; Stuart A Scott
Journal:  Expert Opin Drug Metab Toxicol       Date:  2015-07-14       Impact factor: 4.481

Review 4.  Genetic regulation of platelet receptor expression and function: application in clinical practice and drug development.

Authors:  Marlene S Williams; Ethan J Weiss; Marc S Sabatine; Daniel I Simon; Wadie F Bahou; Lewis C Becker; Leslie V Parise; Harold L Dauerman; Patricia A French; Susan S Smyth; Richard C Becker
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-12       Impact factor: 8.311

5.  Proteomics and Phosphoproteomics of Circulating Extracellular Vesicles Provide New Insights into Diabetes Pathobiology.

Authors:  Yury O Nunez Lopez; Anton Iliuk; Alejandra M Petrilli; Carley Glass; Anna Casu; Richard E Pratley
Journal:  Int J Mol Sci       Date:  2022-05-21       Impact factor: 6.208

6.  Association of polymorphisms in platelet and hemostasis system genes with acute myocardial infarction.

Authors:  Joshua W Knowles; Huijan Wang; Haruka Itakura; Audrey Southwick; Richard M Myers; Carlos Iribarren; Stephen P Fortmann; Alan S Go; Thomas Quertermous; Mark A Hlatky
Journal:  Am Heart J       Date:  2007-12       Impact factor: 4.749

7.  GPla Polymorphisms Are Associated with Outcomes in Patients at High Cardiovascular Risk.

Authors:  Dominik Rath; Elke Schaeffeler; Stefan Winter; Semjon Levertov; Karin Müller; Michal Droppa; Fabian Stimpfle; Harald F Langer; Meinrad Gawaz; Matthias Schwab; Tobias Geisler
Journal:  Front Cardiovasc Med       Date:  2017-08-21

8.  Association between the Hepatic Lipase Promoter Region Polymorphism (-514 C/T) and the Presence and Severity of Premature Coronary Artery Disease.

Authors:  Hamidreza Goodarzynejad; Mohammadali Boroumand; Mehrdad Behmanesh; Shayan Ziaee; Arash Jalali; Leyla Pourgholi
Journal:  J Tehran Heart Cent       Date:  2017-07

Review 9.  Emerging Factors Implicated in Fibrotic Organ-Associated Thrombosis: The Case of Two Organs.

Authors:  Orly Leiva; Roelof H Bekendam; Brenda D Garcia; Cristal Thompson; Alan Cantor; Vipul Chitalia; Katya Ravid
Journal:  TH Open       Date:  2019-06-07

10.  Association of integrin alpha2 gene variants with ischemic stroke.

Authors:  Mar Matarin; W Mark Brown; John A Hardy; Stephen S Rich; Andrew B Singleton; Robert D Brown; Thomas G Brott; Bradford B Worrall; James F Meschia
Journal:  J Cereb Blood Flow Metab       Date:  2007-05-30       Impact factor: 6.200

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.